Acquired hepatocerebral degeneration: Clinical characteristics and MRI findings

European Journal of Neurology

Volumn 17, Issue 12, 2010, Pages 1463-1470

  Fernandez Rodriguez R ^a   Contreras, A ^a   De Villoria, J G ^a   Grandas, F ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Acquired hepatocerebral degeneration; Ataxia; Globus pallidus; Liver transplantation; Manganese; MRI hyperintensities; Parkinsonism; Portosystemic shunts

Indexed keywords

ANTIPARKINSON AGENT; CABERGOLINE; LACTULOSE; LEVODOPA; METOCLOPRAMIDE; PAROMOMYCIN;

ACQUIRED HEPATOCEREBRAL DEGENERATION; ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOBUS PALLIDUS; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MEDICAL RECORD REVIEW; MOTOR DYSFUNCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PORTOSYSTEMIC ANASTOMOSIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN RESTRICTION; RISK FACTOR; TREATMENT OUTCOME; TREATMENT RESPONSE; WILSON DISEASE;

AGED; ANTIPARKINSON AGENTS; BRAIN; CHRONIC DISEASE; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SPAIN;

EID: 78649586710     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03076.x     Document Type: Article

References (57)

1. Woerkom W. La cirrhose hepatique avec alterations dan les centres nerveux evoluant chez des sujets d'age moyen. Nouvelle Iconographie de la Salpetrie. Clinique Maladies Systeme Nerveux 1914; 7: 41-51.
2. Victor M, Adams R, Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicin 1965; 44: 345-396.
3. Jog MS, Lang AE. Chronic acquired hepatocerebral degeneration: case reports and new insights. Mov Disord 1995; 10: 714-722.
4. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis. A distinct subset of acquired hepatocerebral degeneration. Arch Neurol 2003; 60: 521-528.
5. Lizardi-Cervera J, Almeda P, Guevara L, Uribe M. Hepatic encephalopathy: a review. Ann Hepatol 2003; 2: 122-130.
6. Tanzi R, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPasa with homology to the Menkes disease gene. Nat Genet 1993; 5: 344-350.
7. Londianos G, Lovicu M, Solinas P, et al. Delineation of the spectrum of Wilson disease mutations in the Greek population and the identification of six novel mutations. Genetics Tests 2000; 4: 399-402.
8. Pinarbasi B, Kaymakoglu S, Matur Z, et al. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 2009; 43: 176-181.
9. Lewis M, MacQuillan G, Bamford J, Howdle P. Delayed myelopathic presentation of the acquired hepatocerebral degeneration syndrome. Neurology 2000; 54: 1011.
10. Conn H, Rössle M, Levy L, Glocker F. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting. Scand J Gastroenterol 2006; 41: 619-628.
11. Ferrara J, Jankovic J. Acquired hepatocerebral degeneration. J Neurol 2009; 256: 320-332.
12. Stracciari A, Mattarozzi K, D'Alessandro R, Baldin E, Guarino M. Cognitive functioning in chronic acquired hepatocerebral degeneration. Metab Brain Dis 2008; 23: 155-160.
13. Summerskill W, Davidson E, Sherlock S, Steiner R. The neuro-psychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation. Q J Med 1956; 25: 245-266.
14. Read A, Sherlock S, Laidlaw J, Walker J. The neuro-psychiatric syndromes associated with chronic liver disease and a extensive portal-systemic collateral circulation. Q J Med 1967; 36: 135-150.
15. Taylor-Robinson S, Oatridge A, Hajnal J, Burroughs A, McIntyre N, Desouza N. MR imaging of the basal ganglia in chronic liver disease: correlation of T1- weighted and magnetisation transfer contrast measurements with liver disfunction and neuropsychiatric status. Metab Brain Dis 1995; 10: 175-188.
16. Basile A, Jones E. Ammonia and gabaergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy. Hepatology 1997; 25: 1303.
17. Rose C, Butterworth R, Zayed J, et al. Manganese deposition in basal ganglia structures results from both portal- systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-644.
18. Park N, Park J, Choi Y, et al. Whole blood manganese correlates with high signal intensities on T1-weighted MRI patients with liver cirrhosis. Neurotoxicology 2003; 24: 909-915.
19. Huang C, Chu N, Lu C, Chen R, Schulzer M, Calne D. The natural history of neurological manganism over 18 years. Parkinsonism Relat Disord 2007; 13: 143-145.
20. Huang C, Lu C, Chu N, et al. Progression after chronic manganese exposure. Neurology 1993; 43: 1479-1483.
21. Pal P, Samii A, Calne D. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 1999; 20: 227-238.
22. Stepens A, Logina I, Liguts V, et al. A Parkinsonian syndrome in methcathinone users and the role of manganese. N Eng J Med 2008; 358: 1009-1017.
23. Klos K, Ahlskog J, Kumar N, et al. Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology 2006; 67: 1984-1989.
24. Jover R, Compañy L, Gutiérrez A, et al. Clinical significance of extrapyramidal signs in patients with cirrhosis. J Hepatol 2005; 42: 659-665.
25. Abbott W, Thomson A, Steadman C, et al. Child -Pugh class, nutritional indicators and early liver transplant outcome. Hepatogastroenterology 2001; 48: 823-827.
26. Folstein M, Folstein S, Mchugh P. Mini-Mental State: a practical method for grading the cognitive cognitive state of patients for the clinicians. J Am Soc Psych Res 1975; 12: 189-198.
27. Krieger S, Jauss M, Jansen O, et al. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation. J Hepatol 1997; 27: 121-126.
28. Saporta M, André C, Bahia P, et al. Acquired hepatocerebral degeneration without overt liver disease. Neurology 2004; 63: 1981-1982.
29. Mizoguchi N, Nishimura Y, Ono H, Sakura N. Manganese elevations in blood of children with congenital portosystemic shunts. Eur J Pediatr 2001; 160: 247-250.
30. Nolte W, Wilftang J, Schindler C, Unterberg K, Finkenstaed M, Niedmann P. Bright basal ganglia in T1- weighted magnetic resonance images are frequent in patients with portal vein thrombosis without liver cirrhosis and not suggestive of hepatic encephalopathy. J Hepatol 1998; 29: 443-449.
31. Machado J, Gaspar S, Barbosa V, Bina J, Matos H. High intensity signal in basal ganglia on T1 weighted images: case report in Manson's schistosomiasis with portal systemic encephalopathy. Arq Neuropsiquiatr 1999; 57: 306-310.
32. Herz R, Halbfass H, Rössle M, Waldmann D, Gerok W. Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy. Klin Wochenschr 1985; 63: 409-418.
33. Bleasel A, Waugh R, McCaughan G. Development of chronic hepatocerebral degeneration eight years after a distal splenorenal (Warren) shunt. Gut 1989; 30: 1419-1423.
34. Kurlan R, Shoulson I. Differential diagnosis of facial chorea. Adv Neurol 1988; 49: 225-237.
35. Thobosis S, Giraud P, Debat P, et al. Orofacial dyskinesias in a patient primary biliary cirrhosis: a clinicopathological case report and review. Mov Disord 2002; 17: 415-419.
36. Finlayson M, Superville B. Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 1981; 104: 79-95.
37. Fitzgeral K, Mikalunas V, Rubin H, Carthey R, Vanagunas A, Craig R. Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 1999; 23: 333-336.
38. Kafritsa Y, Fell J, Long S, Bynevelt M, Taylor W, Milla P. Long term outcome of brain manganese deposition in patients on home parenteral nutrition. Arch Dis Child 1998; 79: 263-265.
39. De Bie R, Gladstone R, Strafella A, Ko J, Lang A. Manganese - induced parkinsonism associated with methcathinone (Ephedrone) abuse. Arch Neurol 2007; 64: 886-889.
40. Vaquero J, Chung C, Blei A. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol 2003; 2: 12-22.
41. Kleinschmidt-DeMasters B, Filley C, Rojiani A. Overlapping features of extrapontine myelinolysis and acquired chronic (non-Wilsonian) hepatocerebral degeneration. Acta Neuropathol 2006; 112: 605-616.
42. Liu X, Sullivan K, Madl J, Legare M, Tjalkens B. Manganese Induced Neurotoxicity: the role of astroglial- derived nitric oxide in striatal interneuron degeneration. J Toxicol Sci 2006; 91: 521-531.
43. Waskiewicz J, Fresko I, Lenkiewicz A, Albrecht J. Reversible decrease of dopamine D2 receptor density in the striatum of rats with acute hepatic failure. Brain Res 2001; 900: 143-145.
44. Raghavendra R, Giguére J, Pomier-Layrargues G, Butterworth R. Increased activities of MAO- A and MAO-B in autopsied brain tissue from cirrhotic patient with hepatic encephalopathy. Brain Res 1993; 621: 349-352.
45. Jorge A, Sanchez D. Effect of l-Dopa on hepatic coma. Schweiz Rundsch Med Pra 1973; 62: 868-872.
46. Lunzer M, James I, Weinman J, Sherlock S. Treatment of chronic hepatic encephalopathy with levodopa. Gut 1974; 15: 555-561.
47. Morgan M. Cerebral magnetic resonance imaging in patients with chronic liver disease. Metab Brain Dis 1998; 13: 273-290.
48. Iwasa M, Kinosada Y, Watanaba S, et al. Hepatic cirrhosis: magnetisation transfer contrast in the globus pallidus. Neuroradiology 1998; 40: 145-149.
49. Fridman V, Galetta S, Pruitt A, Levine J. MRI findings associated with acute liver failure. Neurology 2009; 72: 2130-2131.
50. Rovira A, Córdoba J, Raguer N, Alonso J. Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution after transplantation. Curr Opin Neurol 2002; 15: 731-737.
51. Wijdicks E, Wiesner R. Acquired (non- Wilsonian) hepatocerebral degeneration: complex management decisions. Liver Transpl 2003; 9: 993-994.
52. Powell E, Pender M, Chalk J, et al. Improvement in chronic hepatocerebral degeneration following liver transplantation. Gastroenterology 1990; 98: 1079-1082.
53. Stracciari A, Guarino M, Pazzaglia P, Marchesini G, Pisi P. Acquired hepatocerebral degeneration: full recovery after liver transplantation. J Neurol Neurosurg Psychiatry 2001; 7: 136-137.
54. Parkes J, Murray-Lyon I, Willians R. Neuropsychiatric and electroencephalographic changes after transplantation of the liver. Q J Med 1970; 156: 515-527.
55. Shulman L, Minagar A, Weiner W. Reversal of parkinsonism following liver transplantation. Neurology 2003; 60: 519.
56. Papapetropoulos S, Singer C. Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration(CAHD). Mov Disord 2005; 20: 1088-1089.
57. Servin-Abad L, Tzakis A, Schiff R, Regev A. Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation. Liver Transpl 2006; 12: 1161-1165.